• レポートコード:D0SP21043 • 出版社/出版日:Transparency Market Research / 2020年8月31日 • レポート形態:英文、PDF、232ページ • 納品方法:Eメール • 産業分類:製薬 |
Single User | ¥857,660 (USD5,795) | ▷ お問い合わせ |
Multi User | ¥1,301,660 (USD8,795) | ▷ お問い合わせ |
Corporate License | ¥1,745,660 (USD11,795) | ▷ お問い合わせ |
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、局所抗生物質の世界市場について調査・分析し、序論、仮定・調査手法、エグゼクティブサマリー、市場概要、キーインサイト、薬剤クラス別(テトラサイクリン、アミノグリコシド、エリスロマイシン、クリンダマイシン、その他)分析、剤形別分析、疾患別分析、製品種類別分析、流通経路別分析、地域別(北米、ヨーロッパ、アジア太平洋、中南米、中東アフリカ)分析、競争状況などの構成でお届けいたします。 ・序論 ・仮定・調査手法 ・エグゼクティブサマリー ・市場概要 ・キーインサイト ・局所抗生物質の世界市場:薬剤クラス別(テトラサイクリン、アミノグリコシド、エリスロマイシン、クリンダマイシン、その他) ・局所抗生物質の世界市場:剤形別 ・局所抗生物質の世界市場:疾患別 ・局所抗生物質の世界市場:製品種類別 ・局所抗生物質の世界市場:流通経路別 ・局所抗生物質の世界市場:地域別(北米、ヨーロッパ、アジア太平洋、中南米、中東アフリカ) ・競争状況 |
Topical Antibiotics Market – Scope of the Report
TMR’s report on the global topical antibiotics market studies the past as well as current growth trends and opportunities to gain valuable insights of these indicators for the market during the forecast period from 2020 to 2030. The report provides the revenue of the global topical antibiotics market for the period 2018–2030, considering 2019 as the base year and 2030 as the forecast year. The report also provides the compound annual growth rate (CAGR %) for the global topical antibiotics market for the forecast period.
The report has been prepared after an extensive primary and secondary research. Primary research involves bulk of research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Extensive secondary research involved referring to key players’ literature, annual reports, press releases, and relevant documents to understand the global topical antibiotics market. Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts have also employed a combination of top-down and bottom-up approaches to study various phenomena in the global topical antibiotics market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Additionally, the report sheds light on the changing competitive dynamics in the global topical antibiotics market. These indices serve as valuable tools for existing market players as well as for entities interested in participating in the global topical antibiotics market. The next section of the global topical antibiotics market report highlights the USPs, which include drivers & restraints impact analysis, value chain analysis, key mergers & acquisitions, regulatory scenario, disease prevalence, and incidence rate of top players operating in the market for topical antibiotics and qualitative analysis of topical antibiotics.
The report analyzes the global topical antibiotics market based on drug class, dosage form, indication, product type, distribution channel, and region. Key segments under each criteria have been studied at length and the market share for each of these at the end of 2027 has been provided. These valuable insights would help market stakeholders in making informed business decisions for investments in the global topical antibiotics market.
Key Questions Answered in Topical Antibiotics Market Report
What will be the sales/revenue generated by different topical antibiotics drug classes across all regions during the forecast period?
What are the major drivers, restraints, and opportunities in the global topical antibiotics market?
Which regional market is set to expand at the fastest CAGR during the forecast period?
Which segment will have the highest revenue globally in 2027 and which drug class segment will expand at the fastest CAGR during the forecast period?
Topical Antibiotics Market – Research Objectives and Research Approach
The comprehensive report on the global topical antibiotics market begins with an overview of the market, followed by scope and objectives of the study. The report provides detailed explanation of the objectives of the study and health care compliances laid down by accredited agencies in the purview of research in the global topical antibiotics market. It is followed by market introduction, market dynamics, and an overview of the global topical antibiotics market, which includes TMR analysis of market drivers, restraints, and trends affecting the growth of the global market. Moreover, Y-o-Y analysis with elaborate insights has been provided to understand the Y-o-Y trends of the global topical antibiotics market.
For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section further divided into smaller ones. The entire report comprises an exhaustive collection of graphs and tables that are appropriately interspersed in the entire compilation. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.
The revenue generated by key topical antibiotics agent manufacturers has been mapped to ascertain the size of the global topical antibiotics market in terms of revenue. The forecast presented here assesses the total revenue generated by topical antibiotics. The report also delves into the competition landscape of the global topical antibiotics market. Key players operating in the global topical antibiotics market have been identified, and each one of these has been profiled for distinguishing business attributes. Company overview, financial standing, recent developments, and SWOT are some of the attributes of players profiled in the global topical antibiotics treatment market report.
レポート目次1. Preface
1.1. Report Scope and Market Segmentation
1.2. Research Highlights
2. Assumptions and Research Methodology
2.1. Assumptions and Acronyms Used
2.2. Research Methodology
3. Executive Summary
3.1. Global Topical Antibiotics Market: Market Snapshot
4. Market Overview
4.1. Global Topical Antibiotics Market: Type Overview
4.2. Global Topical Antibiotics Market: Key Industry Developments
4.3. Market Dynamics
4.4. Drivers and Restraints Snapshot Analysis
4.5. Drivers
4.6. Restraints
4.7. Opportunities
4.8. Global Topical Antibiotics Market Revenue Projections (US$ Mn), 2018–2030
5. Key Insights
5.1. Prevalence of antibiotic resistance
5.2. Regulatory Scenario by Key Countries
5.3. COVID-19 Pandemic Impact on Industry (Value Chain and Short / Mid / Long Term Impact)
5.4. Key Industry Events (Mergers, Acquisitions, Product Launches, Strategic Partnerships, etc.)
5.5. Total Consumption of Antibiotics (Metric Tones
6. Global Topical Antibiotics Market Analysis, by Drug Class
6.1. Introduction
6.2. Global Topical Antibiotics Market Value and Forecast, by Drug Class
6.2.1. Tetracycline
6.2.2. Aminoglycosides
6.2.3. Erythromycin
6.2.4. Clindamycin
6.2.5. Others
6.3. Global Topical Antibiotics Market Analysis, by Drug Class
6.4. Global Topical Antibiotics Market Attractiveness Analysis, by Drug Class
7. Global Topical Antibiotics Market Analysis, by Dosage Form
7.1. Introduction
7.2. Global Topical Antibiotics Market Value and Forecast, by Dosage Form
7.2.1. Ointments
7.2.2. Creams
7.2.3. Powder
7.2.4. Gels
7.2.5. Others
7.3. Global Topical Antibiotics Market Analysis, by Dosage Form
7.4. Global Topical Antibiotics Market Attractiveness Analysis, by Dosage Form
8. Global Topical Antibiotics Market Analysis, by Indication
8.1. Introduction
8.2. Global Topical Antibiotics Market Value and Forecast, by Indication
8.2.1. Skin Infection
8.2.2. Eye Infection
8.2.3. Bromhidrosis
8.2.4. Others
8.3. Global Topical Antibiotics Market Analysis, by Indication
8.4. Global Topical Antibiotics Market Attractiveness Analysis, by Indication
9. Global Topical Antibiotics Market Analysis, by Product Type
9.1. Introduction
9.2. Global Topical Antibiotics Market Value and Forecast, by Product Type
9.2.1. Prescription
9.2.2. OTC
9.3. Global Topical Antibiotics Market Analysis, by Product Type
9.4. Global Topical Antibiotics Market Attractiveness Analysis, by Product Type
10. Global Topical Antibiotics Market Analysis, by Distribution Channel
10.1. Introduction
10.2. Global Topical Antibiotics Market Value and Forecast, by Distribution Channel
10.2.1. Hospital Pharmacies
10.2.2. Retail Pharmacies
10.2.3. Others
10.3. Global Topical Antibiotics Market Analysis, by Distribution Channel
10.4. Global Topical Antibiotics Market Attractiveness Analysis, by Distribution Channel
11. Global Topical Antibiotics Market Analysis, by Region
11.1. Global Topical Antibiotics Market Value and Forecast, by Region, 2018–2030
11.1.1. North America
11.1.2. Europe
11.1.3. Asia Pacific
11.1.4. Latin America
11.1.5. Middle East & Africa
11.2. Global Topical Antibiotics Market Analysis, by Region
11.3. Global Topical Antibiotics Market Attractiveness Analysis, by Region
12. North America Topical Antibiotics Market Analysis
12.1. North America Topical Antibiotics Market
12.2. North America Topical Antibiotics Market Overview
12.3. North America Topical Antibiotics Market Value and Forecast, by Drug Class
12.3.1. Tetracycline
12.3.2. Aminoglycosides
12.3.3. Erythromycin
12.3.4. Clindamycin
12.3.5. Others
12.4. North America Topical Antibiotics Market Value and Forecast, by Dosage Form
12.4.1. Ointments
12.4.2. Creams
12.4.3. Powder
12.4.4. Gels
12.4.5. Others
12.5. North America Topical Antibiotics Market Value and Forecast, by Indication
12.5.1. Skin Infection
12.5.2. Eye Infection
12.5.3. Bromhidrosis
12.5.4. Others
12.6. North America Topical Antibiotics Market Value and Forecast, by Product Type
12.6.1. Prescription
12.6.2. OTC
12.7. North America Topical Antibiotics Market Value and Forecast, by Distribution Channel
12.7.1. Hospital Pharmacies
12.7.2. Retail Pharmacies
12.7.3. Others
12.8. North America Topical Antibiotics Market Forecast, by Country
12.8.1. U.S.
12.8.2. Canada
12.9. North America Topical Antibiotics Market Attractiveness Analysis
12.9.1. By Product Type
12.9.2. By Application
12.9.3. By Distribution Channel
12.9.4. By Country
13. Europe Topical Antibiotics Market Analysis
13.1. Europe Topical Antibiotics Market
13.2. Europe Topical Antibiotics Market Overview
13.3. Europe Topical Antibiotics Market Value and Forecast, by Drug Class
13.3.1. Tetracycline
13.3.2. Aminoglycosides
13.3.3. Erythromycin
13.3.4. Clindamycin
13.3.5. Others
13.4. Europe Topical Antibiotics Market Value and Forecast, by Dosage Form
13.4.1. Ointments
13.4.2. Creams
13.4.3. Powder
13.4.4. Gels
13.4.5. Others
13.5. Europe Topical Antibiotics Market Value and Forecast, by Indication
13.5.1. Skin Infection
13.5.2. Eye Infection
13.5.3. Bromhidrosis
13.5.4. Others
13.6. Europe Topical Antibiotics Market Value and Forecast, by Product Type
13.6.1. Prescription
13.6.2. OTC
13.7. Europe Topical Antibiotics Market Value and Forecast, by Distribution Channel
13.7.1. Hospital Pharmacies
13.7.2. Retail Pharmacies
13.7.3. Others
13.8. Europe Topical Antibiotics Market Forecast, by Country/Sub-region
13.8.1. U.K.
13.8.2. France
13.8.3. Germany
13.8.4. Spain
13.8.5. Italy
13.8.6. Rest of Europe
13.9. Europe Topical Antibiotics Market Attractiveness Analysis
13.9.1. By Product Type
13.9.2. By Application
13.9.3. By Route of Administration
13.9.4. By Distribution Channel
13.9.5. By Country/Sub-region
14. Asia Pacific Topical Antibiotics Market Analysis
14.1. Asia Pacific Topical Antibiotics Market
14.2. Asia Pacific Topical Antibiotics Market Overview
14.3. Asia Pacific Topical Antibiotics Market Value and Forecast, by Drug Class
14.3.1. Tetracycline
14.3.2. Aminoglycosides
14.3.3. Erythromycin
14.3.4. Clindamycin
14.3.5. Others
14.4. Asia Pacific Topical Antibiotics Market Value and Forecast, by Dosage Form
14.4.1. Ointments
14.4.2. Creams
14.4.3. Powder
14.4.4. Gels
14.4.5. Others
14.5. Asia Pacific Topical Antibiotics Market Value and Forecast, by Indication
14.5.1. Skin Infection
14.5.2. Eye Infection
14.5.3. Bromhidrosis
14.5.4. Others
14.6. Asia Pacific Topical Antibiotics Market Value and Forecast, by Product Type
14.6.1. Prescription
14.6.2. OTC
14.7. Asia Pacific Topical Antibiotics Market Value and Forecast, by Distribution Channel
14.7.1. Hospital Pharmacies
14.7.2. Retail Pharmacies
14.7.3. Others
14.8. Asia Pacific Topical Antibiotics Market Forecast, by Country/Sub-region
14.8.1. China
14.8.2. India
14.8.3. Japan
14.8.4. Australia & New Zealand
14.8.5. Rest of Asia Pacific
14.9. Asia Pacific Topical Antibiotics Market Attractiveness Analysis
14.9.1. By Product Type
14.9.2. By Application
14.9.3. By Distribution Channel
14.9.4. By Country/Sub-region
15. Latin America Topical Antibiotics Market Analysis
15.1. Latin America Topical Antibiotics Market
15.2. Latin America Topical Antibiotics Market Overview
15.3. Latin America Topical Antibiotics Market Value and Forecast, by Drug Class
15.3.1. Tetracycline
15.3.2. Aminoglycosides
15.3.3. Erythromycin
15.3.4. Clindamycin
15.3.5. Others
15.4. Latin America Topical Antibiotics Market Value and Forecast, by Dosage Form
15.4.1. Ointments
15.4.2. Creams
15.4.3. Powder
15.4.4. Gels
15.4.5. Others
15.5. Latin America Topical Antibiotics Market Value and Forecast, by Indication
15.5.1. Skin Infection
15.5.2. Eye Infection
15.5.3. Bromhidrosis
15.5.4. Others
15.6. Latin America Topical Antibiotics Market Value and Forecast, by Product Type
15.6.1. Prescription
15.6.2. OTC
15.7. Latin America Topical Antibiotics Market Value and Forecast, by Distribution Channel
15.7.1. Hospital Pharmacies
15.7.2. Retail Pharmacies
15.7.3. Others
15.8. Latin America Topical Antibiotics Market Forecast, by Country/Sub-region
15.8.1. Brazil
15.8.2. Mexico
15.8.3. Rest of Latin America
15.9. Latin America Topical Antibiotics Market Attractiveness Analysis
15.9.1. By Product Type
15.9.2. By Application
15.9.3. By Distribution Channel
15.9.4. By Country/Sub-region
16. Middle East & Africa Topical Antibiotics Market Analysis
16.1. Middle East & Africa Topical Antibiotics Market
16.2. Middle East & Africa Topical Antibiotics Market Overview
16.3. Middle East & Africa Topical Antibiotics Market Value and Forecast, by Drug Class
16.3.1. Tetracycline
16.3.2. Aminoglycosides
16.3.3. Erythromycin
16.3.4. Clindamycin
16.3.5. Others
16.4. Middle East & Africa Topical Antibiotics Market Value and Forecast, by Dosage Form
16.4.1. Ointments
16.4.2. Creams
16.4.3. Powder
16.4.4. Gels
16.4.5. Others
16.5. Middle East & Africa Topical Antibiotics Market Value and Forecast, by Indication
16.5.1. Skin Infection
16.5.2. Eye Infection
16.5.3. Bromhidrosis
16.5.4. Others
16.6. Middle East & Africa Topical Antibiotics Market Value and Forecast, by Product Type
16.6.1. Prescription
16.6.2. OTC
16.7. Middle East & Africa Topical Antibiotics Market Value and Forecast, by Distribution Channel
16.7.1. Hospital Pharmacies
16.7.2. Retail Pharmacies
16.7.3. Others
16.8. Middle East & Africa Topical Antibiotics Market Forecast, by Country/Sub-region
16.8.1. GCC Countries
16.8.2. South Africa
16.8.3. Rest of Middle East & Africa
16.9. Middle East & Africa Topical Antibiotics Market Attractiveness Analysis
16.9.1. By Product Type
16.9.2. By Application
16.9.3. By Distribution Channel
16.9.4. By Country/Sub-region
17. Competitive Landscape
17.1. Company Profiles
17.1.1. Novartis AG
17.1.1.1. Overview (HQ, Employee Strength, Business Segments)
17.1.1.2. Financials
17.1.1.3. Recent Developments
17.1.1.4. Strategy
17.1.2. GlaxoSmithKline plc
17.1.2.1. Overview (HQ, Employee Strength, Business Segments)
17.1.2.2. Financials
17.1.2.3. Recent Developments
17.1.2.4. Strategy
17.1.3. Perrigo Company plc
17.1.3.1. Overview (HQ, Employee Strength, Business Segments)
17.1.3.2. Financials
17.1.3.3. Recent Developments
17.1.3.4. Strategy
17.1.4. Pfizer, Inc.
17.1.4.1. Overview (HQ, Employee Strength, Business Segments)
17.1.4.2. Financials
17.1.4.3. Recent Developments
17.1.4.4. Strategy
17.1.5. Almirall, S.A.
17.1.5.1. Overview (HQ, Employee Strength, Business Segments)
17.1.5.2. Financials
17.1.5.3. Recent Developments
17.1.5.4. Strategy
17.1.6. Bausch Health Companies, Inc. (Valeant Pharmaceuticals International, Inc.)
17.1.6.1. Overview (HQ, Employee Strength, Business Segments)
17.1.6.2. Financials
17.1.6.3. Recent Developments
17.1.6.4. Strategy
17.1.7. Medimetriks Pharmaceuticals, Inc.
17.1.7.1. Overview (HQ, Employee Strength, Business Segments)
17.1.7.2. Financials
17.1.7.3. Recent Developments
17.1.7.4. Strategy
17.1.8. Taro Pharmaceutical Industries Ltd.
17.1.8.1. Overview (HQ, Employee Strength, Business Segments)
17.1.8.2. Financials
17.1.8.3. Recent Developments
17.1.8.4. Strategy
17.1.9. Mayne Pharma Group Limited
17.1.9.1. Overview (HQ, Employee Strength, Business Segments)
17.1.9.2. Financials
17.1.9.3. Recent Developments
17.1.9.4. Strategy
List of TablesTABLE 1 Global Topical Antibiotics Market Value (US$ Mn) Forecast, by Drug Class, 2018–2030
TABLE 2 Global Topical Antibiotics Market Value (US$ Mn) Forecast, by Dosage Form, 2018–2030
TABLE 3 Global Topical Antibiotics Market Value (US$ Mn) Forecast, by Indication, 2018–2030
TABLE 4 Global Topical Antibiotics Market Value (US$ Mn) Forecast, by Product Type, 2018–2030
TABLE 5 Global Topical Antibiotics Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030
TABLE 6 Global Topical Antibiotics Market Value (US$ Mn) Forecast, by Region, 2018–2030
TABLE 7 North America Topical Antibiotics Market Value (US$ Mn) Forecast, by Country, 2018–2030
TABLE 8 North America Topical Antibiotics Market Value (US$ Mn) Forecast, by Drug Class, 2018–2030
TABLE 9 North America Topical Antibiotics Market Value (US$ Mn) Forecast, by Dosage Form, 2018–2030
TABLE 10 North America Topical Antibiotics Market Value (US$ Mn) Forecast, by Indication, 2018–2030
TABLE 11 North America Topical Antibiotics Market Value (US$ Mn) Forecast, by Product Type, 2018–2030
TABLE 12 North America Topical Antibiotics Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030
TABLE 13 Europe Topical Antibiotics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
TABLE 14 Europe Topical Antibiotics Market Value (US$ Mn) Forecast, by Drug Class 2018–2030
TABLE 15 Europe Topical Antibiotics Market Value (US$ Mn) Forecast, by Dosage Form, 2018–2030
TABLE 16 Europe Topical Antibiotics Market Value (US$ Mn) Forecast, by Indication 2018–2030
TABLE 17 Europe Topical Antibiotics Market Value (US$ Mn) Forecast, by Product Type2018–2030
TABLE 18 Europe Topical Antibiotics Market Value (US$ Mn) Forecast, by Distribution Channel 2018–2030
TABLE 19 Asia Pacific Topical Antibiotics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
TABLE 20 Asia Pacific Topical Antibiotics Market Value (US$ Mn) Forecast, by Drug Class, 2018–2030
TABLE 21 Asia Pacific Topical Antibiotics Market Value (US$ Mn) Forecast, by Dosage Form, 2018–2030
TABLE 22 Asia Pacific Topical Antibiotics Market Size (US$ Mn) Forecast, by Indication, 2018–2030
TABLE 23 Asia Pacific Topical Antibiotics Market Size (US$ Mn) Forecast, by Product Type, 2018–2030
TABLE 24 Asia Pacific Topical Antibiotics Market Size (US$ Mn) Forecast, by Distribution Channel, 2018–2030
TABLE 25 Latin America Topical Antibiotics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
TABLE 26 Latin America Topical Antibiotics Market Value (US$ Mn) Forecast, by Drug Class, 2018–2030
TABLE 27 Latin America Topical Antibiotics Market Value (US$ Mn) Forecast, by Dosage Form, 2018–2030
TABLE 28 Latin America Topical Antibiotics Market Value (US$ Mn) Forecast, by Indication, 2018–2030
TABLE 29 Latin America Topical Antibiotics Market Value (US$ Mn) Forecast, by Product Type, 2018–2030
TABLE 30 Latin America Topical Antibiotics Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030
TABLE 31 Middle East & Africa Topical Antibiotics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
TABLE 32 Middle East & Africa Topical Antibiotics Market Value (US$ Mn) Forecast, by Drug Class, 2018–2030
TABLE 33 Middle East & Africa Topical Antibiotics Market Value (US$ Mn) Forecast, by Dosage Form, 2018–2030
TABLE 34 Middle East & Africa Topical Antibiotics Market Value (US$ Mn) Forecast, by Indication, 2018–2030
TABLE 35 Middle East & Africa Topical Antibiotics Market Value (US$ Mn) Forecast, by Product Type, 2018–2030
TABLE 36 Middle East & Africa Topical Antibiotics Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030